S. Wen, J. Zeng, L. Zhong, J. Ye, and X. Lai, “The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma: Nivolumab and lenvatinib in the treatment of HCC”, Cell Mol Biol (Noisy-le-grand), vol. 68, no. 11, pp. 53–57, Nov. 2022.